Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
|
Pharma Marketing Velocity Turning Digital Maturity Into Impact
Pharma marketing velocity connects tools, teams, and compliance systems to drive faster digital execution, improve doctor engagement, and boost marketing ROI.
|
Pharma Marketing Automation for Outcome Based Measurement
Pharma marketing automation replaces vanity metrics with real outcomes by tracking doctor engagement, prescription growth, and patient adherence.
|
Best Healthcare Marketing Agencies Transforming Pharma Growth
If you’re leading marketing for a pharma brand in India, you already know the challenge isn’t ideas it’s execution. The gap between what’s planned and what gets delivered keeps widening. Best…
|
Precision Health Campaigns Driving Smarter Pharma Growth
Pharma marketing is shifting from broad awareness to precision-driven communication. For years, brands relied on repetitive messaging and field promotions that treated every doctor or patient the…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
